Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study
Identifieur interne : 000638 ( France/Extraction ); précédent : 000637; suivant : 000639Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study
Auteurs : Colin R. Simpson [Royaume-Uni] ; Lewis D. Ritchie [Royaume-Uni] ; Chris Robertson [Royaume-Uni, France] ; Aziz Sheikh [Royaume-Uni] ; Jim Mcmenamin [Royaume-Uni]Source :
- Lancet. Infectious diseases : (print) [ 1473-3099 ] ; 2012.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Vaccin.
English descriptors
- KwdEn :
Abstract
Background A targeted vaccination programme for pandemic H1N1 2009 influenza was introduced in Scotland, UK, in October, 2009. We sought to assess the effectiveness of this vaccine in a sample of the Scottish population during the 2009-10 pandemic. Methods We assessed the effectiveness of the Scottish pandemic H1N12009 influenza vaccination with a retrospective cohort design. We linked data of patient-level primary care, hospital records, death certification, and virological swabs to construct our cohort. We estimated vaccine effectiveness in a nationally representative sample of the Scottish population by establishing the risk of hospital admission and death (adjusted for potential confounders) resulting from influenza-related morbidity in vaccinated and unvaccinated patients and laboratory-confirmed cases of influenza H1N1 2009 in a subset of patients. Findings Pandemic H1N1 2009 influenza vaccination began in week 43 of 2009 (Oct 21, 2009) and was given to 38 296 (15.5%, 95% CI 15.4-15.6) of 247178 people by the end of the study period (Jan 31, 2010). 208 882 (85%) people were unvaccinated. There were 5207 emergency hospital admissions and 579 deaths in the unvaccinated population and 924 hospital admissions and 71 deaths in the vaccinated population during 23 893 359 person-days of observation. The effectiveness of H1N1 vaccination for prevention of emergency hospital admissions from influenza-related disorders was 19.5% (95% CI 0.8-34.7). The vaccine's effectiveness in preventing laboratory-confirmed influenza was 77.0% (95% CI 2.0-95.0). Interpretation Pandemic H1N12009 influenza vaccination was associated with protection against pandemic influenza and a reduction in hospital admissions from influenza-related disorders in Scotland during the 2009-10 pandemic.
Url:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000534
- to stream PascalFrancis, to step Curation: 001904
- to stream PascalFrancis, to step Checkpoint: 000665
- to stream Main, to step Merge: 002201
- to stream Hal, to step Corpus: 000180
- to stream Hal, to step Curation: 000180
- to stream Hal, to step Checkpoint: 000571
- to stream Main, to step Merge: 001A00
- to stream Main, to step Curation: 002141
- to stream Main, to step Exploration: 002141
Links to Exploration step
Pascal:12-0366222Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study</title>
<author><name sortKey="Simpson, Colin R" sort="Simpson, Colin R" uniqKey="Simpson C" first="Colin R." last="Simpson">Colin R. Simpson</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Allergy and Respiratory Research Group, Centre for Population Health Sciences, The University of Edinburgh</s1>
<s2>Edinburgh</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Édimbourg</settlement>
<region type="country">Écosse</region>
</placeName>
<orgName type="university">Université d'Édimbourg</orgName>
</affiliation>
</author>
<author><name sortKey="Ritchie, Lewis D" sort="Ritchie, Lewis D" uniqKey="Ritchie L" first="Lewis D." last="Ritchie">Lewis D. Ritchie</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Centre of Academic Primary Care, University of Aberdeen</s1>
<s2>Aberdeen</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Aberdeen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Robertson, Chris" sort="Robertson, Chris" uniqKey="Robertson C" first="Chris" last="Robertson">Chris Robertson</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Mathematics and Statistics, University of Strathclyde</s1>
<s2>Glasgow</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Glasgow</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Health Protection Scotland</s1>
<s2>Glasgow</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Health Protection Scotland</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><inist:fA14 i1="05"><s1>International Prevention Research Institute</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sheikh, Aziz" sort="Sheikh, Aziz" uniqKey="Sheikh A" first="Aziz" last="Sheikh">Aziz Sheikh</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Allergy and Respiratory Research Group, Centre for Population Health Sciences, The University of Edinburgh</s1>
<s2>Edinburgh</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Édimbourg</settlement>
<region type="country">Écosse</region>
</placeName>
<orgName type="university">Université d'Édimbourg</orgName>
</affiliation>
</author>
<author><name sortKey="Mcmenamin, Jim" sort="Mcmenamin, Jim" uniqKey="Mcmenamin J" first="Jim" last="Mcmenamin">Jim Mcmenamin</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Health Protection Scotland</s1>
<s2>Glasgow</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Health Protection Scotland</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0366222</idno>
<date when="2012">2012</date>
<idno type="stanalyst">PASCAL 12-0366222 INIST</idno>
<idno type="RBID">Pascal:12-0366222</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000534</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001904</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000665</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000665</idno>
<idno type="wicri:doubleKey">1473-3099:2012:Simpson C:effectiveness:of:h</idno>
<idno type="wicri:Area/Main/Merge">002201</idno>
<idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-01262963</idno>
<idno type="url">https://hal.archives-ouvertes.fr/hal-01262963</idno>
<idno type="wicri:Area/Hal/Corpus">000180</idno>
<idno type="wicri:Area/Hal/Curation">000180</idno>
<idno type="wicri:Area/Hal/Checkpoint">000571</idno>
<idno type="wicri:explorRef" wicri:stream="Hal" wicri:step="Checkpoint">000571</idno>
<idno type="wicri:doubleKey">1473-3099:2012:Simpson C:effectiveness:of:h</idno>
<idno type="wicri:Area/Main/Merge">001A00</idno>
<idno type="wicri:Area/Main/Curation">002141</idno>
<idno type="wicri:Area/Main/Exploration">002141</idno>
<idno type="wicri:Area/France/Extraction">000638</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study</title>
<author><name sortKey="Simpson, Colin R" sort="Simpson, Colin R" uniqKey="Simpson C" first="Colin R." last="Simpson">Colin R. Simpson</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Allergy and Respiratory Research Group, Centre for Population Health Sciences, The University of Edinburgh</s1>
<s2>Edinburgh</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Édimbourg</settlement>
<region type="country">Écosse</region>
</placeName>
<orgName type="university">Université d'Édimbourg</orgName>
</affiliation>
</author>
<author><name sortKey="Ritchie, Lewis D" sort="Ritchie, Lewis D" uniqKey="Ritchie L" first="Lewis D." last="Ritchie">Lewis D. Ritchie</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Centre of Academic Primary Care, University of Aberdeen</s1>
<s2>Aberdeen</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Aberdeen</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Robertson, Chris" sort="Robertson, Chris" uniqKey="Robertson C" first="Chris" last="Robertson">Chris Robertson</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Mathematics and Statistics, University of Strathclyde</s1>
<s2>Glasgow</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Glasgow</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Health Protection Scotland</s1>
<s2>Glasgow</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Health Protection Scotland</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3"><inist:fA14 i1="05"><s1>International Prevention Research Institute</s1>
<s2>Lyon</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sheikh, Aziz" sort="Sheikh, Aziz" uniqKey="Sheikh A" first="Aziz" last="Sheikh">Aziz Sheikh</name>
<affiliation wicri:level="4"><inist:fA14 i1="01"><s1>Allergy and Respiratory Research Group, Centre for Population Health Sciences, The University of Edinburgh</s1>
<s2>Edinburgh</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Édimbourg</settlement>
<region type="country">Écosse</region>
</placeName>
<orgName type="university">Université d'Édimbourg</orgName>
</affiliation>
</author>
<author><name sortKey="Mcmenamin, Jim" sort="Mcmenamin, Jim" uniqKey="Mcmenamin J" first="Jim" last="Mcmenamin">Jim Mcmenamin</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Health Protection Scotland</s1>
<s2>Glasgow</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Health Protection Scotland</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Lancet. Infectious diseases : (print)</title>
<title level="j" type="abbreviated">Lancet. Infect. dis. : (print)</title>
<idno type="ISSN">1473-3099</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Lancet. Infectious diseases : (print)</title>
<title level="j" type="abbreviated">Lancet. Infect. dis. : (print)</title>
<idno type="ISSN">1473-3099</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cohort study</term>
<term>Immunoprophylaxis</term>
<term>Influenza A</term>
<term>Prevention</term>
<term>Scotland</term>
<term>Vaccine</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Grippe A</term>
<term>Immunoprophylaxie</term>
<term>Prévention</term>
<term>Vaccin</term>
<term>Ecosse</term>
<term>Etude cohorte</term>
<term>Pandémie</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Vaccin</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background A targeted vaccination programme for pandemic H1N1 2009 influenza was introduced in Scotland, UK, in October, 2009. We sought to assess the effectiveness of this vaccine in a sample of the Scottish population during the 2009-10 pandemic. Methods We assessed the effectiveness of the Scottish pandemic H1N12009 influenza vaccination with a retrospective cohort design. We linked data of patient-level primary care, hospital records, death certification, and virological swabs to construct our cohort. We estimated vaccine effectiveness in a nationally representative sample of the Scottish population by establishing the risk of hospital admission and death (adjusted for potential confounders) resulting from influenza-related morbidity in vaccinated and unvaccinated patients and laboratory-confirmed cases of influenza H1N1 2009 in a subset of patients. Findings Pandemic H1N1 2009 influenza vaccination began in week 43 of 2009 (Oct 21, 2009) and was given to 38 296 (15.5%, 95% CI 15.4-15.6) of 247178 people by the end of the study period (Jan 31, 2010). 208 882 (85%) people were unvaccinated. There were 5207 emergency hospital admissions and 579 deaths in the unvaccinated population and 924 hospital admissions and 71 deaths in the vaccinated population during 23 893 359 person-days of observation. The effectiveness of H1N1 vaccination for prevention of emergency hospital admissions from influenza-related disorders was 19.5% (95% CI 0.8-34.7). The vaccine's effectiveness in preventing laboratory-confirmed influenza was 77.0% (95% CI 2.0-95.0). Interpretation Pandemic H1N12009 influenza vaccination was associated with protection against pandemic influenza and a reduction in hospital admissions from influenza-related disorders in Scotland during the 2009-10 pandemic.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
<li>Royaume-Uni</li>
</country>
<region><li>Auvergne-Rhône-Alpes</li>
<li>Rhône-Alpes</li>
<li>Écosse</li>
</region>
<settlement><li>Lyon</li>
<li>Édimbourg</li>
</settlement>
<orgName><li>Université d'Édimbourg</li>
</orgName>
</list>
<tree><country name="Royaume-Uni"><region name="Écosse"><name sortKey="Simpson, Colin R" sort="Simpson, Colin R" uniqKey="Simpson C" first="Colin R." last="Simpson">Colin R. Simpson</name>
</region>
<name sortKey="Mcmenamin, Jim" sort="Mcmenamin, Jim" uniqKey="Mcmenamin J" first="Jim" last="Mcmenamin">Jim Mcmenamin</name>
<name sortKey="Ritchie, Lewis D" sort="Ritchie, Lewis D" uniqKey="Ritchie L" first="Lewis D." last="Ritchie">Lewis D. Ritchie</name>
<name sortKey="Robertson, Chris" sort="Robertson, Chris" uniqKey="Robertson C" first="Chris" last="Robertson">Chris Robertson</name>
<name sortKey="Robertson, Chris" sort="Robertson, Chris" uniqKey="Robertson C" first="Chris" last="Robertson">Chris Robertson</name>
<name sortKey="Sheikh, Aziz" sort="Sheikh, Aziz" uniqKey="Sheikh A" first="Aziz" last="Sheikh">Aziz Sheikh</name>
</country>
<country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Robertson, Chris" sort="Robertson, Chris" uniqKey="Robertson C" first="Chris" last="Robertson">Chris Robertson</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/France/Extraction
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000638 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Extraction/biblio.hfd -nk 000638 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= PandemieGrippaleV1 |flux= France |étape= Extraction |type= RBID |clé= Pascal:12-0366222 |texte= Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study }}
This area was generated with Dilib version V0.6.34. |